Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South
Background: Due to diabetes being linked with poorer cervical cancer prognosis, this study aimed to evaluate HPV testing behaviors among females with and without diabetes across the U.S. by geographic area in 2016, 2018, and 2020. Methods: This cross-sectional study used the Behavioral Risk Factor S...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-12-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/13/24/6319 |
| _version_ | 1797506397564305408 |
|---|---|
| author | Cassidi C. McDaniel Hayleigh H. Hallam Tiffany Cadwallader Hee-Yun Lee Chiahung Chou |
| author_facet | Cassidi C. McDaniel Hayleigh H. Hallam Tiffany Cadwallader Hee-Yun Lee Chiahung Chou |
| author_sort | Cassidi C. McDaniel |
| collection | DOAJ |
| description | Background: Due to diabetes being linked with poorer cervical cancer prognosis, this study aimed to evaluate HPV testing behaviors among females with and without diabetes across the U.S. by geographic area in 2016, 2018, and 2020. Methods: This cross-sectional study used the Behavioral Risk Factor Surveillance System (BRFSS) from 2016, 2018, and 2020. The study population included females aged 25–69 years old, stratified by self-reported diabetes status. The primary outcome measure was cervical cancer screening behavior, which was evaluated by self-reported HPV test uptake/receipt (yes/no). Results: A total of 361,546 females from across the U.S. were sampled. Within the study population combined from all study years, the overall likelihood of receiving an HPV test was significantly lower among females with diabetes [37.95% (95% CI: 36.87–39.04)] compared to those without diabetes [46.21% (95% CI: 45.84–46.58)] (<i>p</i> < 0.001). Screening rates with HPV tests were lowest among females with diabetes in the South in 2016 (29.32% (95% CI: 26.82–31.83)), 2018 (39.63% (95% CI: 36.30–42.96)), and 2020 (41.02% (95% CI: 37.60–44.45)). Conclusions: Females with diabetes are screening with HPV tests less frequently than females without diabetes, and females living in the South, particularly states in the Deep South, report the lowest rates of HPV testing. |
| first_indexed | 2024-03-10T04:32:05Z |
| format | Article |
| id | doaj.art-be29ca37f4a041b5a987183a8f3b7b5e |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-10T04:32:05Z |
| publishDate | 2021-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-be29ca37f4a041b5a987183a8f3b7b5e2023-11-23T04:06:59ZengMDPI AGCancers2072-66942021-12-011324631910.3390/cancers13246319Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep SouthCassidi C. McDaniel0Hayleigh H. Hallam1Tiffany Cadwallader2Hee-Yun Lee3Chiahung Chou4Department of Health Outcomes Research and Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USADepartment of Health Outcomes Research and Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USADepartment of Health Outcomes Research and Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USASchool of Social Work, The University of Alabama, Tuscaloosa, AL 35487, USADepartment of Health Outcomes Research and Policy, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USABackground: Due to diabetes being linked with poorer cervical cancer prognosis, this study aimed to evaluate HPV testing behaviors among females with and without diabetes across the U.S. by geographic area in 2016, 2018, and 2020. Methods: This cross-sectional study used the Behavioral Risk Factor Surveillance System (BRFSS) from 2016, 2018, and 2020. The study population included females aged 25–69 years old, stratified by self-reported diabetes status. The primary outcome measure was cervical cancer screening behavior, which was evaluated by self-reported HPV test uptake/receipt (yes/no). Results: A total of 361,546 females from across the U.S. were sampled. Within the study population combined from all study years, the overall likelihood of receiving an HPV test was significantly lower among females with diabetes [37.95% (95% CI: 36.87–39.04)] compared to those without diabetes [46.21% (95% CI: 45.84–46.58)] (<i>p</i> < 0.001). Screening rates with HPV tests were lowest among females with diabetes in the South in 2016 (29.32% (95% CI: 26.82–31.83)), 2018 (39.63% (95% CI: 36.30–42.96)), and 2020 (41.02% (95% CI: 37.60–44.45)). Conclusions: Females with diabetes are screening with HPV tests less frequently than females without diabetes, and females living in the South, particularly states in the Deep South, report the lowest rates of HPV testing.https://www.mdpi.com/2072-6694/13/24/6319cervical cancercancer screeningHPVdiabeteshealth disparities |
| spellingShingle | Cassidi C. McDaniel Hayleigh H. Hallam Tiffany Cadwallader Hee-Yun Lee Chiahung Chou Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South Cancers cervical cancer cancer screening HPV diabetes health disparities |
| title | Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South |
| title_full | Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South |
| title_fullStr | Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South |
| title_full_unstemmed | Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South |
| title_short | Disparities in Cervical Cancer Screening with HPV Test among Females with Diabetes in the Deep South |
| title_sort | disparities in cervical cancer screening with hpv test among females with diabetes in the deep south |
| topic | cervical cancer cancer screening HPV diabetes health disparities |
| url | https://www.mdpi.com/2072-6694/13/24/6319 |
| work_keys_str_mv | AT cassidicmcdaniel disparitiesincervicalcancerscreeningwithhpvtestamongfemaleswithdiabetesinthedeepsouth AT hayleighhhallam disparitiesincervicalcancerscreeningwithhpvtestamongfemaleswithdiabetesinthedeepsouth AT tiffanycadwallader disparitiesincervicalcancerscreeningwithhpvtestamongfemaleswithdiabetesinthedeepsouth AT heeyunlee disparitiesincervicalcancerscreeningwithhpvtestamongfemaleswithdiabetesinthedeepsouth AT chiahungchou disparitiesincervicalcancerscreeningwithhpvtestamongfemaleswithdiabetesinthedeepsouth |